8 results on '"Manca, M. L."'
Search Results
2. Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study
- Author
-
Baldacci, F., Lista, S., Manca, M. L., Chiesa, P. A., Cavedo, E., Lemercier, P., Zetterberg, H., Blennow, K., Habert, M. -O., Potier, M. C., Dubois, B., Vergallo, A., Hampel, H., Bakardjian, H., Benali, H., Bertin, H., Bonheur, J., Boukadida, L., Boukerrou, N., Chiesa, P., Colliot, O., Dubois, M., Epelbaum, S., Gagliardi, G., Genthon, R., Houot, M., Kas, A., Lamari, F., Levy, M., Metzinger, C., Mochel, F., Nyasse, F., Poisson, C., Potier, M. -C., Revillon, M., Santos, A., Andrade, K. S., Sole, M., Surtee, M., de Schotten, M. T., Younsi, N., Afshar, M., Aguilar, L. F., Akman-Anderson, L., Arenas, J., Avila, J., Babiloni, C., Batrla, R., Benda, N., Black, K. L., Bokde, A. L. W., Bonuccelli, U., Broich, K., Cacciola, F., Caraci, F., Caruso, G., Castrillo, J., Ceravolo, R., Corbo, M., Corvol, J. -C., Claudio, A., Cummings, J. L., Depypere, H., Duggento, A., Emanuele, E., Escott-Price, V., Federoff, H., Ferretti, M. T., Fiandaca, M., Frank, R. A., Garaci, F., Geerts, H., Giacobini, E., Giorgi, F. S., Goetzl, E. J., Graziani, M., Haberkamp, M., Hanisch, B., Herholz, K., Hernandez, F., Imbimbo, B. P., Kapogiannis, D., Karran, E., Kiddle, S. J., Kim, S. H., Koronyo, Y., Koronyo-Hamaoui, M., Langevin, T., Lehericy, S., Llavero, F., Lorenceau, J., Lucia, A., Mango, D., Mapstone, M., Neri, C., Nistico, R., O'Bryant, S. E., Palermo, G., Perry, G., Ritchie, C., Rossi, S., Saidi, A., Santarnecchi, E., Schneider, L. S., Sporns, O., Toschi, N., Valenzuela, P. L., Vellas, B., Verdooner, S. R., Villain, N., Virecoulon Giudici, K., Watling, M., Welikovitch, L. A., Woodcock, J., Younesi, E., Zugaza, J. L., Alzheimer Precision Medicine [CHU Pitié-Salpétriêre] (GRC 21 AMP), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), University of Pisa - Università di Pisa, Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Service de Neurologie [CHU Pitié-Salpêtrière], IFR70-CHU Pitié-Salpêtrière [AP-HP], Institut de la Mémoire et de la Maladie d'Alzheimer [Paris] (IM2A), Sorbonne Université (SU), Sahlgrenska Academy at University of Gothenburg [Göteborg], University College of London [London] (UCL), UK Dementia Research Institute (UK DRI), Laboratoire d'Imagerie Biomédicale (LIB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Service de médecine nucléaire [CHU Pitié-Salpétrière], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), and Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Male ,BIOMARKER ,0301 basic medicine ,Oncology ,Aging ,Neurology ,[SDV]Life Sciences [q-bio] ,Disease ,Neurodegenerative ,Alzheimer's Disease ,Medical and Health Sciences ,lcsh:RC346-429 ,MESH: Cognitive Dysfunction ,Alzheimer’s disease ,Biomarkers ,Mild cognitive impairment ,Neurofilament light chain ,Subjective memory complainers ,Tau ,0302 clinical medicine ,Neurofilament Proteins ,Medicine and Health Sciences ,BRAIN ,MESH: Neurofilament Proteins ,RISK ,Settore FIS/07 ,NEURODEGENERATION ,Cognition ,ASSOCIATION ,MESH: Follow-Up Studies ,Alzheimer's disease ,MESH: Amyloid beta-Peptides ,MESH: tau Proteins ,ALZHEIMERS-DISEASE ,POSITIVITY ,Neurological ,Cohort ,Biomarker (medicine) ,Female ,medicine.medical_specialty ,Cognitive Neuroscience ,tau Proteins ,Subjective ,Affect (psychology) ,VALIDATION ,lcsh:RC321-571 ,subjective memory complainers ,mild cognitive impairment ,biomarkers ,s disease ,03 medical and health sciences ,memory complainers ,Clinical Research ,Alzheimer Disease ,Internal medicine ,NEUROFILAMENT LIGHT-CHAIN ,Acquired Cognitive Impairment ,medicine ,Humans ,Cognitive Dysfunction ,Vitamin B12 ,Allele ,Alzheimer’ ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,lcsh:Neurology. Diseases of the nervous system ,Amyloid beta-Peptides ,MESH: Humans ,business.industry ,Research ,Prevention ,Neurosciences ,Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) ,Alzheimer Precision Medicine Initiative ,COGNITIVE IMPAIRMENT ,MESH: Male ,Brain Disorders ,030104 developmental biology ,MESH: Biomarkers ,Dementia ,Neurology (clinical) ,business ,INSIGHT-preAD study group ,MESH: Female ,MESH: Alzheimer Disease ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Background Plasma neurofilament light (NFL) and total Tau (t-Tau) proteins are candidate biomarkers for early stages of Alzheimer’s disease (AD). The impact of biological factors on their plasma concentrations in individuals with subjective memory complaints (SMC) has been poorly explored. We longitudinally investigate the effect of sex, age, APOE ε4 allele, comorbidities, brain amyloid-β (Aβ) burden, and cognitive scores on plasma NFL and t-Tau concentrations in cognitively healthy individuals with SMC, a condition associated with AD development. Methods Three hundred sixteen and 79 individuals, respectively, have baseline and three-time point assessments (at baseline, 1-year, and 3-year follow-up) of the two biomarkers. Plasma biomarkers were measured with an ultrasensitive assay in a mono-center cohort (INSIGHT-preAD study). Results We show an effect of age on plasma NFL, with women having a higher increase of plasma t-Tau concentrations compared to men, over time. The APOE ε4 allele does not affect the biomarker concentrations while plasma vitamin B12 deficiency is associated with higher plasma t-Tau concentrations. Both biomarkers are correlated and increase over time. Baseline NFL is related to the rate of Aβ deposition at 2-year follow-up in the left-posterior cingulate and the inferior parietal gyri. Baseline plasma NFL and the rate of change of plasma t-Tau are inversely associated with cognitive score. Conclusion We find that plasma NFL and t-Tau longitudinal trajectories are affected by age and female sex, respectively, in SMC individuals. Exploring the influence of biological variables on AD biomarkers is crucial for their clinical validation in blood.
- Published
- 2020
3. Coronary artery disease and type 2 diabetes: A proteomic study
- Author
-
Ferrannini, G., Manca, M. L., Magnoni, M., Andreotti, F., Andreini, D., Latini, R., Maseri, A., Maggioni, A. P., Ostroff, R. M., Williams, S. A., Ferrannini, E., Andreotti F. (ORCID:0000-0002-1456-6430), Ferrannini, G., Manca, M. L., Magnoni, M., Andreotti, F., Andreini, D., Latini, R., Maseri, A., Maggioni, A. P., Ostroff, R. M., Williams, S. A., Ferrannini, E., and Andreotti F. (ORCID:0000-0002-1456-6430)
- Abstract
OBJECTIVE Coronary artery disease (CAD) is a major challenge in patients with type 2 diabetes (T2D). Coronary computed tomography angiography (CCTA) provides a detailed anatomic map of the coronary circulation. Proteomics are increasingly used to improve diagnostic and therapeutic algorithms. We hypothesized that the protein panel is differentially associated with T2D and CAD. RESEARCH DESIGN AND METHODS In CAPIRE (Coronary Atherosclerosis in Outlier Subjects: Protective and Novel Individual Risk Factors Evaluationda cohort of 528 individuals with no previous cardiovascular event undergoing CCTA), participants were grouped into CAD2 (clean coronaries) and CAD1 (diffuse lumen narrowing or plaques). Plasma proteins were screened by aptamer analysis. Two-way partial least squares was used to simultaneously rank proteins by diabetes status and CAD. RESULTS Though CAD1 was more prevalent among participants with T2D (HbA1c 6.7 6 1.1%) than those without diabetes (56 vs. 30%, P < 0.0001), CCTA-based atherosclerosis burden did not differ. Of the 20 top-ranking proteins, 15 were associated with both T2D and CAD, and 3 (osteomodulin, cartilage intermediate-layer protein 15, and HTRA1) were selectively associated with T2D only and 2 (epidermal growth factor receptor and contactin-1) with CAD only. Elevated renin and GDF15, and lower adiponectin, were independently associated with both T2D and CAD. In multivariate analysis adjusting for the Framingham risk panel, patients with T2D were “protected” from CAD if female (P 5 0.007), younger (P 5 0.021), and with lower renin levels (P 5 0.02). CONCLUSIONS We concluded that 1) CAD severity and quality do not differ between participants with T2D and without diabetes; 2) renin, GDF15, and adiponectin are shared markers by T2D and CAD; 3) several proteins are specifically associated with T2D or CAD; and 4) in T2D, lower renin levels may protect against CAD.
- Published
- 2020
4. Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study
- Author
-
Fadini, G. P., Solini, A., Manca, M. L., Zatti, G., Karamouzis, I., Di Benedetto, A., Frittitta, L., Avogaro, A., Consoli, Agostino, Formoso, Gloria, Grossi, Giovanni, Pucci, Achiropita, Sesti, Giorgio, Andreozzi, Francesco, Capobianco, Giuseppe, Gatti, Adriano, Bonadonna, Riccardo, Zavaroni, Ivana, Dei Cas, Alessandra, Felace, Giuseppe, Li Volsi, Patrizia, Buzzetti, Raffaella, Leto, Gaetano, Sorice, Gian Pio, D’Angelo, Paola, Morano, Susanna, Bossi, Antonio Carlo, Duratorre, Edoardo, Franzetti, Ivano, Morpurgo, Paola Silvia, Orsi, Emanuela, Querci, Fabrizio, Boemi, Massimo, D’Angelo, Federica, Petrelli, Massimiliano, Aimaretti, Gianluca, Karamouzis, Ioannis, Cavalot, Franco, Saglietti, Giuseppe, Cazzetta, Giuliana, Cervone, Silvestre, Devangelio, Eleonora, Lamacchia, Olga, Arena, Salvatore, Di Benedetto, Antonino, Frittitta, Lucia, Giordano, Carla, Piro, Salvatore, Rizzo, Manfredi, Chianetta, Roberta, Mannina, Carlo, Anichini, Roberto, Penno, Giuseppe, Solini, Anna, Fattor, Bruno, Bonora, Enzo, Cigolini, Massimo, Lapolla, Annunziata, Chilelli, Nino Cristiano, Poli, Maurizio, Simioni, Natalino, Frison, Vera, Vinci, Carmela, Fadini, G P, Solini, A, Manca, M L, Zatti, G, Karamouzis, I, Di Benedetto, A, Frittitta, L, and Avogaro, A, Giordano, C
- Subjects
Male ,Epidemiology ,Endocrinology, Diabetes and Metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Kidney ,Type 2 diabete ,Settore MED/13 - Endocrinologia ,0302 clinical medicine ,Endocrinology ,80 and over ,Medicine ,Diabetic Nephropathies ,030212 general & internal medicine ,Aged, 80 and over ,education.field_of_study ,General Medicine ,Insulin resistance ,Nephropathy ,Protective ,Diabetes and Metabolism ,Phenotype ,Lipotoxicity ,Female ,Type 2 ,Human ,Glomerular Filtration Rate ,medicine.medical_specialty ,Population ,Renal function ,Internal Medicine ,Diabetes Mellitus, Type 2 ,Humans ,03 medical and health sciences ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,education ,Aged ,business.industry ,medicine.disease ,Diabetic Nephropathie ,business ,Kidney disease - Abstract
AimsType 2 diabetes (T2D) accelerates the decline in glomerular function; however, some individuals do not develop chronic kidney disease despite advanced age and long-lasting T2D. We aimed to phenotype patients with T2D aged 80years or older who presented with a fully preserved kidney function.MethodsFrom an Italian population of 281,217 T2D outpatients, we collected data on demographics, anthropometrics, diabetes duration, HbA1c, fasting plasma glucose, lipids, liver enzymes, estimated glomerular filtration rate (eGFR), albumin excretion rate (AER), chronic complications, and medication use. We primarily compared patients with a fully preserved kidney function (eGFR>90ml/min/1.73m(2) and AER
- Published
- 2018
5. Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
- Author
-
Moriconi D, Manca ML, Anselmino M, Rebelos E, Bellini R, Taddei S, Ferrannini E, and Nannipieri M
- Subjects
- Body Mass Index, Follow-Up Studies, Glycated Hemoglobin analysis, Humans, Recurrence, Remission Induction, Treatment Outcome, Diabetes Mellitus, Type 2 drug therapy, Diabetes Mellitus, Type 2 epidemiology, Diabetes Mellitus, Type 2 surgery, Gastric Bypass, Obesity, Morbid complications, Obesity, Morbid epidemiology, Obesity, Morbid surgery
- Abstract
Aims: To assess the impact of bariatric surgery on remission and relapse of type 2 diabetes mellitus (T2DM) at 10 years of follow-up and analyze predictive factors., Materials and Methods: Eighty-eight obese subjects undergoing Roux-en-Y gastric bypass (RYGB) and 25 subjects assigned to medical therapy (MT) were evaluated every year for 10 years. T2DM remission was defined by the American Diabetes Association criteria., Results: Body mass index (BMI), fasting glucose, and haemoglobin A1c (HbA1c) improved more markedly in RYGB than MT patients throughout the 10-year period. Post-surgery remission rates were 74% and 53% at 1 and 10 years, respectively, while remission did not occur in MT patients. One-year post-surgery, BMI decreased more in subjects with remission than in those without, but no further decrease was observed thereafter. By partial-least-squares analysis, T2DM duration, baseline HbA1c, and ensuing insulin therapy were the strongest predictors of remission. Remission was achieved at one year in 91% of patients with T2DM duration < 4 years, and 79% of them remained in remission at 10 years. On the contrary only 42% of patients with T2DM duration ≥ 4 years achieved remission, which was maintained only in 6% at the end of 10 years. By survival analysis, patients with T2DM duration < 4 years had higher remission rates than those with duration ≥ 4 years (hazards ratio (HR) 3.1 [95%CI 1.8-5.7]). Relapse did not occur before two years post-surgery and was much less frequent in patients with < 4- vs ≥ 4-year duration (HR 11.8 [4.9-29.4])., Conclusions: Short T2DM duration and good glycemic control before RYGB surgery were the best requisites for a long-lasting T2DM remission, whereas weight loss had no impact on the long-term relapse of T2DM., (Copyright © 2021 Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Novel drug delivery systems for natural extracts: The case study of Vitis Vinifera extract-SiO 2 nanocomposites.
- Author
-
Scano A, Ebau F, Manca ML, Cabras V, Cesare Marincola F, Manconi M, Pilloni M, Fadda AM, and Ennas G
- Subjects
- Drug Delivery Systems, Phenols analysis, Antioxidants chemistry, Nanocomposites chemistry, Plant Extracts chemistry, Silicon Dioxide chemistry, Vitis
- Abstract
Ball Milling technique has been used to prepare for the first time Vitis Vinifera extract-silica nanocomposites (VV-SiO
2 NCs), which combine the pharmacological effects of the extract with the effectiveness of silica as drug delivery system and active component in the treatment of wound healing. Different contents (1.0, 9.0 and 33.0 wt%) of Vitis Vinifera ethanolic extract were loaded into the silica matrix by grinding the extract with fumed silica using a planetary mill apparatus. The effect of the starting mixture composition and milling time on the final products was examined. The efficiency of the milling process was studied by X-ray Powder Diffraction, Nuclear Magnetic Resonance, and Infrared Spectroscopy, indicating that the natural extract was not affected by the increasing of the milling time. The successful loading of the extract was demonstrated by Nitrogen adsorption/desorption measurements, which showed a decrease in the SSA and pore volume of the silica with the increasing of the extract amount. Morphology of the nanocomposites, investigated by Scanning Electron Microscopy, showed an increased agglomeration in the nanocomposites with the increment of the VV extract amount. Studies on the total phenol quantification and antioxidant activity of the natural extract before and after incorporation in the silica matrix were also carried out. The obtained results indicate that the milling process does not alter the VV extract components, which result to be embedded in the silica matrix. An increase of the antioxidant activity with the increment of the extract amount in the nanocomposites, up to values comparable to the pure VV extract, was also observed., (Copyright © 2018 Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
7. Elevated serum creatinine and hyponatraemia as prognostic factors in canine acute pancreatitis.
- Author
-
Marchetti V, Gori E, Lippi I, Luchetti E, Manca ML, and Pierini A
- Subjects
- Animals, Dog Diseases diagnostic imaging, Dog Diseases mortality, Dogs, Female, Hyponatremia diagnostic imaging, Italy, Male, Pancreatitis blood, Pancreatitis diagnostic imaging, Pancreatitis mortality, Prognosis, Retrospective Studies, Schools, Veterinary, Severity of Illness Index, Creatinine blood, Dog Diseases blood, Hyponatremia veterinary, Pancreatitis veterinary
- Abstract
Objective: To evaluate prognostic factors for canine acute pancreatitis (AP) based on clinical and laboratory data that can be easily assessed in veterinary practice., Design: Retrospective study between January 2010 and December 2013., Methods: The diagnosis of AP was based on clinical signs and an abnormal SNAP® cPL™ test result, concurrently with an ultrasound pattern suggestive of pancreatitis. Dogs were divided into survivors and non-survivors. We evaluated 12 clinical and laboratory parameters: respiratory rate, rectal temperature, white blood cells, haematocrit, total serum proteins, albumin, creatinine, cholesterol, total and ionised calcium, sodium and potassium. Clinical and clinicopathological data were statistically compared between survivors and non-survivors. A value of P < 0.05 was considered significant and P < 0.01 as highly significant. The odds ratio (OR) was calculated., Results: The study enrolled 50 client-owned dogs with a diagnosis of AP. Serum creatinine (P = 0.017) and sodium (P = 0.004) correlated significantly with the outcome. Serum sodium < 139.0 mmol/L (139.0 mEq/L) and serum creatinine > 212 μmol/L (2.4 mg/dL) were associated significantly with poor prognosis. Azotaemia (OR 12.5; 95% confidence interval (CI) 1.32-118.48) and hyponatraemia (OR 4.9; 95% CI 1.36-17.64) were associated with increased risk of death., Conclusions: In dogs with AP, hyponatraemia and azotaemia seem to be significantly associated with an increased risk of death., (© 2017 Australian Veterinary Association.)
- Published
- 2017
- Full Text
- View/download PDF
8. Development of curcumin loaded sodium hyaluronate immobilized vesicles (hyalurosomes) and their potential on skin inflammation and wound restoring.
- Author
-
Manca ML, Castangia I, Zaru M, Nácher A, Valenti D, Fernàndez-Busquets X, Fadda AM, and Manconi M
- Subjects
- Animals, Cells, Cultured, Curcumin chemistry, Curcumin pharmacology, Humans, Microscopy, Electron, Transmission, Swine, Curcumin administration & dosage, Dermatitis prevention & control, Hyaluronic Acid chemistry, Skin drug effects, Wound Healing drug effects
- Abstract
In the present work new highly biocompatible nanovesicles were developed using polyanion sodium hyaluronate to form polymer immobilized vesicles, so called hyalurosomes. Curcumin, at high concentration was loaded into hyalurosomes and physico-chemical properties and in vitro/in vivo performances of the formulations were compared to those of liposomes having the same lipid and drug content. Vesicles were prepared by direct addition of dispersion containing the polysaccharide sodium hyaluronate and the polyphenol curcumin to a commercial mixture of soy phospholipids, thus avoiding the use of organic solvents. An extensive study was carried out on the physico-chemical features and properties of curcumin-loaded hyalurosomes and liposomes. Cryogenic transmission electron microscopy and small-angle X-ray scattering showed that vesicles were spherical, uni- or oligolamellar and small in size (112-220 nm). The in vitro percutaneous curcumin delivery studies on intact skin showed an improved ability of hyalurosomes to favour a fast drug deposition in the whole skin. Hyalurosomes as well as liposomes were biocompatible, protected in vitro human keratinocytes from oxidative stress damages and promoted tissue remodelling through cellular proliferation and migration. Moreover, in vivo tests underlined a good effectiveness of curcumin-loaded hyalurosomes to counteract 12-O-tetradecanoilphorbol (TPA)-produced inflammation and injuries, diminishing oedema formation, myeloperoxydase activity and providing an extensive skin reepithelization. Thanks to the one-step and environmentally-friendly preparation method, component biocompatibility and safety, good in vitro and in vivo performances, the hyalurosomes appear as promising nanocarriers for cosmetic and pharmaceutical applications., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.